Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 18, 2010
Monodispersed DOTA-PEG-conjugated anti-TAG-72 diabody has low kidney uptake and high tumor-to-blood ratios resulting in improved 64Cu PETLin Li, Fabio Turatti, Desiree Crow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2004
Pilot trial evaluating an 123I-labeled 80-kilodalton engineered anticarcinoembryonic antigen antibody fragment (cT84.66 minibody) in patients with colorectal cancerJeffrey Y C Wong, David Z Chu, Lawrence E Williams, et al.
Bioconjugate Chemistry|March 15, 2011
Site-specific conjugation of monodispersed DOTA-PEGn to a thiolated diabody reveals the effect of increasing peg size on kidney clearance and tumor uptake with improved 64-copper PET imagingLin Li, Desiree Crow, Fabio Turatti, et al.
Cancer Research|July 5, 2005
Optimizing radiolabeled engineered anti-p185HER2 antibody fragments for in vivo imagingTove Olafsen, Vania E Kenanova, Gobalakrishnan Sundaresan, et al.
IEEE Access : Practical Innovations, Open Solutions|May 22, 2020
Prototype Small-Animal PET-CT Imaging System for Image-guided Radiation TherapyEkaterina Mikhaylova, Jamison Brooks, Darren Zuro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2003
A Phase I trial of 90Y-anti-carcinoembryonic antigen chimeric T84.66 radioimmunotherapy with 5-fluorouracil in patients with metastatic colorectal cancerJeffrey Y C Wong, Stephen Shibata, Lawrence E Williams, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 6, 2000
High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragmentA M Wu, P J Yazaki, S w Tsai, et al.
Cancer Research|February 8, 2005
Tailoring the pharmacokinetics and positron emission tomography imaging properties of anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragmentsVania Kenanova, Tove Olafsen, Desiree M Crow, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 26, 2022
First-In-Human Pilot PET Immunoimaging Study of 64Cu-Anti-Carcinoembryonic Antigen Monoclonal Antibody (hT84.66-M5A) in Patients with Carcinoembryonic Antigen-Producing CancersJeffrey Y C Wong, David M Yamauchi, Vikram Adhikarla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2019
ImmunoPET, [64Cu]Cu-DOTA-Anti-CD33 PET-CT, Imaging of an AML Xenograft ModelSargur Madabushi Srideshikan, Jamison Brooks, Darren Zuro, et al.
Pageof 9